RxDoctor Payments DataLook up a doctor →

Turgut Zia, MD

Internal Medicine · Milwaukee, WINPI 1699783894

Payments from drug & device makers

$17,377in general payments, 2019–2025

Across 964 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$2K
  • Gilead$1K
  • Novo Nordisk$961
  • Pfizer$912
  • Boehringer Ingelheim$859
  • plus $8K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)221$3,159
AstraZeneca97$1,672
Gilead55$1,326
Novo Nordisk52$961
Pfizer51$912
Boehringer Ingelheim50$859
GSK44$725
Takeda Pharmaceuticals U.S.A., Inc.33$685
Lilly USA, LLC34$640
Johnson & Johnson24$460
Lundbeck LLC21$442
Bayer16$355
Insmed, Inc.15$349
Daiichi Sankyo Inc.16$339
Vanda Pharmaceuticals Inc.19$335
Novartis18$328
Astellas Pharma US Inc12$279
Dexcom, Inc.14$263
Amgen14$263
Merck14$206
Abbott12$205
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$169
Mallinckrodt Hospital Products Inc.6$122
Mylan Specialty L.p.6$121
Sunovion Pharmaceuticals Inc.12$119
Medtronic(2 entities)4$117
Harmony Biosciences LLC5$112
Axsome Therapeutics, Inc.4$96
E.r. Squibb & Sons, L.L.C.3$92
Eisai Inc.5$92
Kowa Pharmaceuticals America, Inc.5$92
Myriad Women's Health, Inc.2$79
Alnylam Pharmaceuticals Inc.3$76
IBSA Pharma Inc.5$72
Biohaven Pharmaceutical Holding Company Ltd.4$71
Exact Sciences3$71
Viatris Specialty LLC3$69
Idorsia Pharmaceuticals US Inc3$67
Madrigal Pharmaceuticals2$65
Philips North America LLC3$62
Sanofi3$61
Ultragenyx Pharmaceutical Inc.3$61
Sanofi-aventis U.S. LLC3$58
Ardelyx, Inc.2$56
OPKO Pharmaceuticals, LLC2$52
Inspire Medical Systems, Inc.1$49
Amneal Pharmaceuticals LLC3$47
Electromed, Inc.3$44
Biohaven Pharmaceuticals, Inc.2$38
Collegium Pharmaceutical, Inc.2$37
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$35
Liquidia Technologies, Inc.1$35
Almatica Pharma LLC1$30
Insulet Corporation1$25
Grifols USA, LLC1$23
Vifor Pharma, Inc.1$20
Regeneron Healthcare Solutions, Inc.1$20
Evoke Pharma, Inc.1$19
Neurocrine Biosciences, Inc.1$19
Otsuka America Pharmaceutical, Inc.1$18

How this compares

$17,377 in reported general payments places this provider in the 95th percentile of 1,411 internal medicine providers in Wisconsin.

See all internal medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$268,614
Medicare patients
588
Services billed
3,199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →